Login / Signup

The role of dosimetry and biological effects in metastatic castration-resistant prostate cancer (mCRPC) patients treated with 223Ra: first in human study.

Rosa SciutoSandra ReaSara UnganiaAntonella TestaValentina DiniMaria Antonella TabocchiniClarice PatronoAntonella SorianiValentina PalmaRaffaella MarconiLidia Strigari
Published in: Journal of experimental & clinical cancer research : CR (2021)
The pilot study has been approved from the Ethics Committee of Regina Elena National Cancer Institute (N:RS1083/18-2111).
Keyphrases
  • endothelial cells
  • squamous cell carcinoma
  • public health
  • small cell lung cancer
  • rheumatoid arthritis
  • big data
  • induced pluripotent stem cells
  • drug administration
  • systemic sclerosis
  • interstitial lung disease